Loading…
Tesla BioHealing, Inc. was warned for manufacturing and marketing the Tesla MedBed Generator and Tesla BioHealer as unapproved medical devices intended to treat serious conditions including terminal cancers, stroke paralysis, Lyme Disease, Alzheimer's, and Epilepsy by activating cellular self-repair mechanisms through "Life Force Energy." The company violated federal law by failing to obtain required premarket approval (PMA) or investigational device exemption (IDE) authorization before commercializing these devices, rendering them adulterated under section 501(f)(1)(B) of the Federal Food, Drug, and Cosmetic Act. The FDA inspection was conducted at the company's Milford, Delaware facility from March 20-23, 2023, and the warning letter was issued August 10, 2023.